Daniel L Hertz, PharmD, PhD
Advertisement
Articles by Daniel L Hertz, PharmD, PhD
Advertisement
Latest Updated Articles
DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer ChemotherapyPublished: April 25th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
4
Expert Discusses Early Safety and Tolerability Findings for VMT-α-NET in Neuroendocrine Tumors | ESMO 2025
5
